With respect to the role of MCP-1 in attracting monocytes to the site of vascular injury, our results provide one of the mechanistic clues for higher risk of cardiovascular diseases in subjects lacking GSTM1 (GSTM1-null genotype), which is even more pronounced in uremic milieu in ESRD patients. The gene discussed is CCL2; the disease is cardiovascular disorder.